Current Events 2 <Jan 2025>
* jewishstudies israel project1. Title of Article: Japan's Kaneka buys israeli medical startup in 100,000,000 deal
1.1. URL:
1.2. WHO:
This article is about Endostream Medical and Kaneka.
- Endostream is a startup that develops aneurysm devices.
- Kaneka corp is an international chemical manufacturing company.
1.3. WHAT:
The Japanese company Kaneka Corporation acquired 96.8% the Israeli medical device startup EndoStream Medical for $100 million. Kaneka aims to expand its healthcare business through the acquisition of EndoStream, which developed the Nautilus device. Nautilus is an intrasaccular flow diverter for treating brain aneurysms. Nautilus features a self-conforming structure that adapts to various neck anatomies and enhances coil stability. It has shown promising results in clinical studies and is set for US approval in 2026 and Japanese approval in 2027.
1.4. WHAT
- Kaneka corp was founded in 1949
- Kaneka bought Endostream
1.5. WHERE:
Everywhere, mostly japan and israel.
1.6. Why:
Kaneka's acquisition of EndoStream Medical is significant because it could revolutionize treatment options for patients with brain aneurysms. The Nautilus device, developed by EndoStream, offers a potentially game-changing approach to addressing this serious health condition. By expanding access to this innovative technology, Kaneka aims to improve patient outcomes and quality of life for those affected by brain aneurysms in europe.
2. Elsewhere
2.1. References
2.2. In my garden
Notes that link to this note (AKA backlinks).